1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia


Opción 1: Descargar recurso

Detalles del recurso

Descripción

Glioblastoma multiforme (GBM) are the most malignant among brain tumors. They are frequently refractory to chemotherapy and radiotherapy with mean patient survival of approximately 6 months, despite surgical intervention. The highly glycolytic nature of glioblastomas describes their propensity to metabolize glucose to lactic acid at an elevated rate. To survive, GBMs efflux lactic acid to the tumor microenvironment through transmembrane transporters denoted monocarboxylate transporters (MCTs). We hypothesized that inhibition of MCT function would impair the glycolytic metabolism and affect both glioma invasiveness and survival. We examined the effect on invasiveness with α-cyano-4-hydroxy-cinnamic acid (ACCA, 4CIN, CHCA), a small-molecule inhibitor of lactate transport, through Matrigel-based and organotypic (brain) slice culture invasive assays using U87-MG and U251-MG glioma cells. We then conducted studies in immunodeficient rats by stereotaxic intracranial implantation of the glioma cells followed by programmed orthotopic application of ACCA through osmotic pumps. Effect on the implanted tumor was monitored by small-animal magnetic resonance imaging. Our assays indicated that glioma invasion was markedly impaired when lactate efflux was inhibited. Convection-enhanced delivery of inhibitor to the tumor bed caused tumor necrosis, with 50% of the animals surviving beyond the experimental end points (3 months after inhibitor exhaustion). Most importantly, control animals did not display any adverse neurologic effects during orthotopic administration of ACCA to brain through programmed delivery. These results indicate the clinical potential of targeting lactate efflux in glioma through delivery of small-molecule inhibitors of MCTs either to the tumor bed or to the postsurgical resection cavity.

Pertenece a

PubMed Central (PMC3 - NLM DTD)  

Autor(es)

Colen, Chaim B -  Shen, Yimin -  Ghoddoussi, Farhad -  Yu, Pingyang -  Francis, Todd B -  Koch, Brandon J -  Monterey, Michael D -  Galloway, Matthew P -  Sloan, Andrew E -  Mathupala, Saroj P - 

Id.: 54060132

Idioma: inglés  - 

Versión: 1.0

Estado: Final

Palabras claveResearch Article - 

Tipo de recurso: Text  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

Requerimientos técnicos:  Browser: Any - 

Fecha de contribución: 01-ago-2011

Contacto:

Localización:

Otros recursos de la misma colección

  1. Salmonella Protein AvrA Activates the STAT3 Signaling Pathway in Colon Cancer1 Salmonella infection in humans can become chronic, which leads to low-grade persistent inflammation....
  2. The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells1 The TWIST1 embryonic transcription factor displays biphasic functions during the course of carcinoge...
  3. Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown1 Pancreatic cancer reveals the worst prognosis among human cancers with little improvement in its cli...
  4. Glycan Sulfation Modulates Dendritic Cell Biology and Tumor Growth1 In cancer, proteoglycans have been found to play roles in facilitating the actions of growth factors...
  5. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence1,2 Head and neck squamous cell carcinomas (HNSCC) exhibit a small population of uniquely tumorigenic ca...

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.